Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
US Department of Justice
Colorcon
Mallinckrodt
AstraZeneca
Express Scripts
Queensland Health
Federal Trade Commission
McKesson

Generated: May 26, 2018

DrugPatentWatch Database Preview

DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dobutamine Hydrochloride In Dextrose 5%, and when can generic versions of Dobutamine Hydrochloride In Dextrose 5% launch?

Dobutamine Hydrochloride In Dextrose 5% is a drug marketed by Hospira and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
Summary for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Drug patent expirations by year for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Medical Subject Heading (MeSH) Categories for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%

US Patents and Regulatory Information for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% dobutamine hydrochloride INJECTABLE;INJECTION 020269-001 Oct 19, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dobutamine hydrochloride INJECTABLE;INJECTION 020255-005 Oct 19, 1993 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dobutamine hydrochloride INJECTABLE;INJECTION 020255-001 Oct 19, 1993 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dobutamine hydrochloride INJECTABLE;INJECTION 020201-003 Oct 19, 1993 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Express Scripts
US Army
Accenture
Dow
Daiichi Sankyo
Johnson and Johnson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.